Biosyent Financial Overview
Biosyent's market cap is currently C$135.98M. The company's EPS TTM is C$0.23; its P/E ratio is 15.46; and it has a dividend yield of 1.66%. Biosyent is scheduled to report earnings on November 20, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
